1. Academic Validation
  2. USP27X negatively regulates antiviral signaling by deubiquitinating RIG-I

USP27X negatively regulates antiviral signaling by deubiquitinating RIG-I

  • PLoS Pathog. 2020 Feb 6;16(2):e1008293. doi: 10.1371/journal.ppat.1008293.
Xinyue Tao 1 2 Bei Chu 1 3 Di Xin 1 Lin Li 1 Qinmiao Sun 1 2
Affiliations

Affiliations

  • 1 State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
  • 2 Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
  • 3 School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China.
Abstract

RIG-I plays important roles in pathogen sensing and activation of Antiviral innate immune responses in response to RNA viruses. RIG-I-mediated signaling must be precisely controlled to maintain innate immune signaling homeostasis. Previous studies demonstrated that lysine 63 (K63)-linked polyubiquitination of RIG-I is vital for its activation, but the mechanisms through which RIG-I is deubiquitinated to control innate immune responses are not well understood. Here we identified USP27X as a negative regulator of Antiviral signaling in response to RNA viruses through siRNA library screening. Further functional studies indicated that USP27X negatively modulated RIG-I-mediated Antiviral signaling in a deubiquitinase-dependent manner. Mechanistically, we found that USP27X removed K63-linked polyubiquitin chains from RIG-I to negatively modulate type I interferon signaling. Collectively, these studies uncover a novel negative regulatory role of USP27X in targeting RIG-I to balance innate immune responses.

Figures